Stakeholder Perspectives of the Inflation Reduction Act’s (2022) Impact on Prescription Drugs
Date
2024-03
Authors
Lieneck, Cristian
McLauchlan, Matthew
Adachi, Valerie
Billings, Roger
Journal Title
Journal ISSN
Volume Title
Publisher
Abstract
IN this review, we examine the impact of the Inflation Reduction Act (IRA) of 2022 on pharmaceutical drugs in the United States, drawing on a diverse range of sources to understand the perceptions of multiple stakeholders and professionals. Findings suggest that the Act, while aiming
to control price inflation, has had a multifaceted impact on the pharmaceutical sector.
Description
Keywords
Inflation Reduction Act, prescription drugs
Citation
Lieneck, C., McLauchlan, M., Adachi, V., & Billings, R. (2024). Stakeholder perspectives of the Inflation Reduction Act’s (2022) impact on prescription drugs. Poster presented at the Health Scholar Showcase, Translational Health Research Center, San Marcos, Texas.